Progyny, Inc. Deferred Income Tax Expense (Benefit)
Progyny, Inc. (PGNY) reported Deferred Income Tax Expense (Benefit) of -$8.12 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-27
- Progyny, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$8.12M.
- Progyny, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$10.46M, a 379.20% decline from fiscal 2023.
- Progyny, Inc. deferred income tax expense (benefit) for fiscal 2023 was $3.75M.
- Progyny, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$6.61M.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$8.12M 10-K · filed 2026-02-27 |
| 2024-12-31 | -$10.46M 10-K · filed 2026-02-27 |
| 2023-12-31 | $3.75M 10-K · filed 2026-02-27 |
| 2022-12-31 | -$6.61M 10-K · filed 2025-03-03 |
| 2021-12-31 | -$33.30M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$37.97M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |